Press Releases

Mithra Pharmaceuticals SA reçoit l’autorisation de lancer son étude d’interaction alimentaire MIT-ES0001-C101
14 August 2015
EN FR

Exercise Overallotment Warrant Denominator
7 August 2015
EN FR NL

Exercise of the Over-allotment Option and End of the Stabilisation Period in Relation to the Initial Public Offering
30 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Announces That it Grew to Record Market Share in Contraception in Belgium
17 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Announces a Positive Evolution of the On-going Pharmacodynamics Studies for its Three-month Implant Zoreline®
17 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Signs Contract Extension with Pharmaceutica SARL
16 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Selects PRA Health Sciences as CRO for Phase III Clinical Trial
16 July 2015
EN FR NL

Transparency Notifications
11 July 2015
EN FR NL

Notification Form – François Fornieri Mithra
11 July 2015
FR

Notification Form – Meusinvest SA Mithra
11 July 2015
FR

Notification Form – Marc Coucke Alychlo NV Mithra
11 July 2015
NL

Notification Form – OGEO Mithra
11 July 2015
FR